Followers | 813 |
Posts | 71327 |
Boards Moderated | 2 |
Alias Born | 01/30/2003 |
Wednesday, April 18, 2012 2:35:39 PM
We are in the middle of our strategic alternatives review, a highly competitive process, as we want to evaluate the various options to capitalize the development of the play going forward. It is unfortunately too early in the process to know whether or not the outcome could involve a potential acquisitor or whether it will involve a different form of equity injection. We expect to provide shareholders with an update on the process in the next 4 to 6 weeks. Also, our year end 2011 financials will be released in late April, and our AGM will be in late July or early August.
Robert
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM